Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | NCF1 | P14598 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.35 |
| ▸ | MAP2K6 | P52564 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9602129 | 0.83 | MGAM (0.48) | IKBKBMGAMALDH1A1MAPTGAA | |
| SCHEMBL5262432 | 0.77 | ESR1 (0.38) | IKBKBALDH1A1GAASMN1; SMN2KDM4E | |
| SCHEMBL5507882 | 0.77 | ALDH1A1 (0.44) | ALDH1A1MAPTSMN1; SMN2CNR2KDM4E | |
| SCHEMBL11620950 | 0.72 | MAPT (0.41) | IKBKBALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL269764 | 0.70 | ALDH1A1 (0.42) | MGAMALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL4717309 | 0.70 | NCF1 (0.46) | IKBKBALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL29540332 | 0.67 | MGAM (0.68) | IKBKBMGAMALDH1A1MAPTGAA | |
| SCHEMBL5748265 | 0.67 | KDM4E (0.44) | IKBKBALDH1A1MAPTGAASMN1; SMN2 | |
| SCHEMBL367913 | 0.67 | MGAM (0.68) | IKBKBMGAMALDH1A1MAPTGAA | |
| SCHEMBL860951 | 0.67 | GRM2 (0.43) | IKBKBKDM4EKMT2ALCKMAP2K3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1646638-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | Enanta Pharmaceuticals, Inc. (US) | 2006-04-19 | — | — | EP | claimed |
| WO-2004108745-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2004-12-16 | — | — | WO | claimed |
| WO-2004108746-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2004-12-16 | — | — | WO | claimed |
| US-20060293503-A1 | Polyaminopyridines and method for producing same | SUMITOMO SEIKA CHEMICALS CO., LTD (JP) | 2006-12-28 | — | — | US | disclosed |
| EP-1669390-A1 | POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1646638-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | Enanta Pharmaceuticals, Inc. (US) | 2006-04-19 | — | — | EP | disclosed |
| EP-1603898-A2 | CHEMICAL DERIVATIVES BINDING VERY SPECIFICALLY WITH G-QUADRUPLEX DNA STRUCTURES AND USE THEREOF AS A SPECIFIC ANTI-CANCER AGENT | Aventis Pharma S.A. (FR) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004108746-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004108745-A2 | 11-12 BICYCLIC ERYTHROMYCIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004072027-A2 | CHEMICAL DERIVATIVES BINDING VERY SPECIFICALLY WITH G-QUADRUPLEX DNA STRUCTURES AND USE THEREOF AS A SPECIFIC ANTI-CANCER AGENT | AVENTIS PHARMA S.A. (FR) | 2004-08-26 | — | — | WO | disclosed |
| EP-0308885-A1 | Derivatives of d-glutamic acid and d-aspartic acid | ABBOTT LABORATORIES (US) | 1989-03-29 | — | — | EP | disclosed |